FFA
ORIC icon

Farther Finance Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Farther Finance Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27K Buy
122
+72
+144% +$653 ﹤0.01% 5302
2026
Q1 		$374 Buy
50
+30
+150% +$341 ﹤0.01% 5332
2025
Q4 		$164 Buy
+20
New +$230 ﹤0.01% 5238
2025
Q3 		– Sell
-922
Closed -$9.36K – 5045
2025
Q2 		$9.36K Buy
+922
New +$6.19K ﹤0.01% 3107

Other funds holding ORIC

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's ORIC Position: Q2 2026 in Review

Farther Finance Advisors increased its Oric Pharmaceuticals (ORIC) stake by 144% in Q2 2026, buying an estimated $653 and bringing the position to 122 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #5302.

Farther Finance Advisors first reported a position in ORIC in Q2 2025 and has held it in 4 quarters since. The position peaked at $9.36K in Q2 2025. 15 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Farther Finance Advisors held 122 shares of Oric Pharmaceuticals worth $1.27K as of Q2 2026.
  • Farther Finance Advisors bought 72 Oric Pharmaceuticals shares in Q2 2026, an estimated $653.
  • Oric Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5302 holding.
  • Farther Finance Advisors first reported a position in Oric Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's Oric Pharmaceuticals position peaked at $9.36K in Q2 2025.
  • 15 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.